Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1993 Oct;36(4):315–321. doi: 10.1111/j.1365-2125.1993.tb00370.x

A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease.

K M Donaldson 1, K D Dawkins 1, D G Waller 1
PMCID: PMC1364684  PMID: 12959309

Abstract

1. The acute haemodynamic effects of intravenous nisoldipine (1, 2, 4 microg kg(-1)) and nifedipine (2.5, 5, 10 microg kg(-1)) were compared in a randomised, within-patient crossover study. Fifteen male patients with stable angina pectoris treated with atenolol were studied after undergoing routine cardiac catheterisation. 2. Nisoldipine caused a dose-related fall in systemic vascular resistance (maximum 22%) associated with an increase in heart rate and cardiac index (18%) and a fall in mean arterial pressure (7%). 3. By contrast, nifedipine was associated with a significant increase in heart rate but systemic vascular resistance, cardiac index and mean arterial pressure remained unaltered. 4. At doses with equivalent effects on heart rate (2 microg kg(-1) nisoldipine; 10 microg kg(-1) nifedipine) acute dosing with nisoldipine caused a significantly greater fall in systemic vascular resistance and increase in cardiac index, whilst nifedipine caused a greater reduction in stroke volume index and left ventricular stroke work index. 5. The results suggest that, when combined with atenolol, acute dosing with nisoldipine may have a more complementary haemodynamic profile than nifedipine. The implications of this finding for chronic oral dosing in patients with impaired left ventricular function should be evaluated.

Full text

PDF
315

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Challenor V. F., Waller D. G., Renwick A. G., George C. F. Slow release nifedipine plus atenolol in chronic stable angina pectoris. Br J Clin Pharmacol. 1989 Nov;28(5):509–516. doi: 10.1111/j.1365-2125.1989.tb03536.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Emanuelsson H., Holmberg S. Mechanisms of angina relief after nifedipine: a hemodynamic and myocardial metabolic study. Circulation. 1983 Jul;68(1):124–130. doi: 10.1161/01.cir.68.1.124. [DOI] [PubMed] [Google Scholar]
  3. Foster T. S., Hamann S. R., Richards V. R., Bryant P. J., Graves D. A., McAllister R. G. Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects. J Clin Pharmacol. 1983 Apr;23(4):161–170. doi: 10.1002/j.1552-4604.1983.tb02720.x. [DOI] [PubMed] [Google Scholar]
  4. Gunther S., Green L., Muller J. E., Mudge G. H., Jr, Grossman W. Prevention of nifedipine of abnormal coronary vasoconstriction in patients with coronary artery disease. Circulation. 1981 Apr;63(4):849–855. doi: 10.1161/01.cir.63.4.849. [DOI] [PubMed] [Google Scholar]
  5. Hills M., Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979 Jul;8(1):7–20. doi: 10.1111/j.1365-2125.1979.tb05903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Joshi P. I., Dalal J. J., Ruttley M. S., Sheridan D. J., Henderson A. H. Nifedipine and left ventricular function in beta-blocked patients. Br Heart J. 1981 Apr;45(4):457–459. doi: 10.1136/hrt.45.4.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kazda S., Garthoff B., Meyer H., Schlossmann K., Stoepel K., Towart R., Vater W., Wehinger E. Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552). Arzneimittelforschung. 1980;30(12):2144–2162. [PubMed] [Google Scholar]
  8. Klugmann S., Salvi A., Camerini F. Haemodynamic effects of nifedipine in heart failure. Br Heart J. 1980 Apr;43(4):440–446. doi: 10.1136/hrt.43.4.440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ludbrook P. A., Tiefenbrunn A. J., Reed F. R., Sobel B. E. Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function. Circulation. 1982 Mar;65(3):489–498. doi: 10.1161/01.cir.65.3.489. [DOI] [PubMed] [Google Scholar]
  10. Lynch P., Dargie H., Krikler S., Krikler D. Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination. Br Med J. 1980 Jul 19;281(6234):184–187. doi: 10.1136/bmj.281.6234.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nienaber C. A., Spielmann R. P., Aschenberg W., Fehr A., Clausen A., Bleifeld W. Comparison of the acute hemodynamic response to intravenous nisoldipine (Bay k 5552) and intravenous nifedipine for left ventricular dysfunction secondary to myocardial infarction. Am J Cardiol. 1987 Oct 1;60(10):836–841. doi: 10.1016/0002-9149(87)91033-2. [DOI] [PubMed] [Google Scholar]
  12. O'Keefe J. C., Creamer J. E., Banim S. O. Efficacy of nisoldipine combined with beta-adrenergic-blocking drugs in the treatment of chronic stable angina. Clin Cardiol. 1987 Jun;10(6):345–350. doi: 10.1002/clc.4960100609. [DOI] [PubMed] [Google Scholar]
  13. Raff W. K., Kosche F., Lochner W. Untersuchungen mit Nifedipine, einer coronargefässerweiternden Substanz mit schneller sublingualer Wirkung. Arzneimittelforschung. 1972 Jan;22(1):33–39. [PubMed] [Google Scholar]
  14. Ram J., Freedman S. B., Ogasawara S., Thomson A., Kelly D. T. Effects of nisoldipine on systemic and leg blood flow, oxygen transport and metabolism, and hemodynamics during exercise in effort angina pectoris. Am J Cardiol. 1989 Apr 1;63(12):802–806. doi: 10.1016/0002-9149(89)90046-5. [DOI] [PubMed] [Google Scholar]
  15. Rowland E., Razis P., Sugrue D., Krikler D. M. Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol. Br Heart J. 1983 Oct;50(4):383–389. doi: 10.1136/hrt.50.4.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schanzenbächer P., Göttfert G., Liebau G., Kochsiek K. Coronary hemodynamic and metabolic effects of nifedipine in patients with coronary artery disease treated with beta-blocking drugs. Am J Cardiol. 1985 Jan 1;55(1):33–36. doi: 10.1016/0002-9149(85)90294-2. [DOI] [PubMed] [Google Scholar]
  17. Schanzenbächer P., Liebau G., Deeg P., Kochsiek K. Effect of intravenous and intracoronary nifedipine on coronary blood flow and myocardial oxygen consumption. Am J Cardiol. 1983 Mar 1;51(5):712–717. doi: 10.1016/s0002-9149(83)80120-9. [DOI] [PubMed] [Google Scholar]
  18. Soward A. L., De Feyter P. J., Hugenholtz P. G., Serruys P. W. Coronary and systemic hemodynamic effects of intravenous nisoldipine. Am J Cardiol. 1986 Dec 1;58(13):1199–1203. doi: 10.1016/0002-9149(86)90381-4. [DOI] [PubMed] [Google Scholar]
  19. Vogt A., Kreuzer H. Hemodynamic effects of nisoldipine in chronic congestive heart failure. Arzneimittelforschung. 1983;33(6):877–879. [PubMed] [Google Scholar]
  20. Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res. 1980 Jul;47(1):1–9. doi: 10.1161/01.res.47.1.1. [DOI] [PubMed] [Google Scholar]
  21. Walley T. J., Heagerty A. M., Woods K. L., Bing R. F., Pohl J. E., Barnett D. B. Acute inotropic effects of intravenous nifedipine and its vehicle compared with saline: a double-blind study of systolic time intervals in normal subjects. Br J Clin Pharmacol. 1988 Feb;25(2):187–193. doi: 10.1111/j.1365-2125.1988.tb03290.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES